1,800
Participants
Start Date
April 10, 2020
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Administration procedures
"Hydrocortisone hemisuccinate / hydrocortisone placebo will be given as 50 mg intravenous bolus every 6 hours;~9 alpha fludrocortisone / 9 alpha fludrocortisone placebo will be given as a 50 μg tablet via a nasogastric tube once per day in the morning.~Study drugs will be started immediately after randomization (day 0 of the study), until discharge from ICU for a maximal duration of 7 days. Study drugs will be stopped without tapering off."
RECRUITING
Department of medical and surgical Intensive Care Unit, Raymond Poincaré Hospital - APHP, Garches
Collaborators (4)
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
Versailles Saint-Quentin-en-Yvelines University
OTHER
Université Paris-Saclay
OTHER
Paris 12 Val de Marne University
OTHER
Commissariat A L'energie Atomique
OTHER_GOV
Beckman Coulter, Inc.
INDUSTRY
Lumedix
UNKNOWN
Elice
UNKNOWN
Biothelis
UNKNOWN
Assistance Publique - Hôpitaux de Paris
OTHER